Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Overview of the biology of type I interferons.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Orally Active 7-Substituted (4-Benzyl-phthalazin-1-yl)-2-methyl-piperazin-1-yl]-nicotinonitriles as Active-site Inhibitors of Sphingosine-1-Phosphate Lyase for the Treatment of Multiple Sclerosis.
[Case report: a case of chronic inflammatory demyelinating polyneuropathy (CIDP) exacerbated by influenza vaccination].
Chronic inflammatory demyelinating polyradiculoneuropathy: revisiting the role of intravenous immmunoglobulins.
BG-12 (dimethyl fumarate): a review of mechanism of action, efficacy, and safety.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Neurodegeneration and Neuroprotection in Multiple Sclerosis.
Perforin Expression by CD4+ Regulatory T Cells Increases at Multiple Sclerosis Relapse: Sex Differences.
The impact of walking speed on the effects of functional electrical stimulation for foot drop in people with multiple sclerosis.
Dose-Escalation Study of T Cell Vaccine in Multiple Sclerosis (DES)
Interferon β-1a therapy for multiple sclerosis during pregnancy: an unresolved issue.
Total-tau in cerebrospinal fluid of patients with multiple sclerosis decreases in secondary progressive stage of disease and reflects degree of brain atrophy.
Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: comparison of tissue-based and cell-based indirect immunofluorescence assays and ELISA.
Frequency of circulating autoreactive T cells committed to myelin determinants in relapsing-remitting multiple sclerosis patients.
Identification of VHY/Dusp15 as a Regulator of Oligodendrocyte Differentiation through a Systematic Genomics Approach.
Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.
Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.
Autoreactive CD19+CD20- Plasma Cells Contribute to Disease Severity of Experimental Autoimmune Encephalomyelitis.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Association Between CD24-P226-C/T Polymorphism and Multiple Sclerosis: A Meta-Analysis.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Prolongation of survival of rat cardiac allografts by T cell vaccination.
Effects of early IL-17A neutralization on disease induction in a primate model of experimental autoimmune encephalomyelitis.
The translational biology of remyelination: Past, present, and future.

Pages